Chronic heart failure: a disease of the brain

作者: Ram B. Singh , Krasimira Hristova , Jan Fedacko , Galal El-Kilany , Germaine Cornelissen

DOI: 10.1007/S10741-018-9747-3

关键词:

摘要: The underlying mechanism for clinical and biochemical manifestations of chronic heart failure (HF) may be due in part to neurohumoral adaptations, such as activation the renin-angiotensin-aldosterone sympathetic nervous systems periphery brain. Internet search discussion with colleagues are methods this study. Since HF is associated autonomic imbalance increased nerve activity a withdrawal parasympathetic activity, it considered brain disease. This phenomenon result an systemic cerebral angiotensin II signaling because plasma humans animals HF. increase enhances through actions on both central peripheral sites during Activation different paraventricular nucleus (PVN), rostral ventrolateral medulla (RVLM), area postrema (AP) release norepinephrine, oxidative stress, inflammation leading cardiac contractility. It possible that blocking type 1 receptors decreases afferent reflex when therapy administered PVN. administration receptor blocker by injection into AP activates sympatho-inhibitory baroreflex indicating blockers act increasing activity. In HF, regions, elevates norepinephrine synthesis inhibits uptake at endings, which contribute Increased circulating enhance sympatho-excitatory chemoreflex inhibit resulting worsening can directly system via subfornical organ outflow dysfunction, failure.

参考文章(34)
John S. Floras, Sympathetic Nervous System Activation in Human Heart Failure: Clinical Implications of an Updated Model Journal of the American College of Cardiology. ,vol. 54, pp. 375- 385 ,(2009) , 10.1016/J.JACC.2009.03.061
Peter A Carson, Christopher M O’Connor, Alan B Miller, Susan Anderson, Robert Belkin, Gerald W Neuberg, John H Wertheimer, David Frid, Anne Cropp, Milton Packer, Circadian rhythm and sudden death in heart failure: results from Prospective Randomized Amlodipine Survival Trial. Journal of the American College of Cardiology. ,vol. 36, pp. 541- 546 ,(2000) , 10.1016/S0735-1097(00)00728-2
Elżbieta Kimak, Magdalena Hałabiś, Patrycja Lachowska-Kotowska, Paweł Kiciński, Grzegorz Dzida, Andrzej Prystupa, Tobiasz Kadas, Piotr Kamieński, Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. Annals of Agricultural and Environmental Medicine. ,vol. 20, pp. 745- 748 ,(2013)
Ian B. Wilkinson, Carmel M. McEniery, Katherine H. Bongaerts, Helen MacCallum, David J. Webb, John R. Cockcroft, Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP) British Journal of Clinical Pharmacology. ,vol. 52, pp. 159- 164 ,(2001) , 10.1046/J.0306-5251.2001.1420.X
John H. Lee, Tara Jarreau, Amit Prasad, Carl Lavie, James O’Keefe, Hector Ventura, Nutritional Assessment in Heart Failure Patients Congestive Heart Failure. ,vol. 17, pp. 199- 203 ,(2011) , 10.1111/J.1751-7133.2011.00239.X
Ram B. Singh, Siddharth Gupta, Parinita Dherange, Fabien De Meester, Agnieszka Wilczynska, Shaan E. Alam, Daniel Pella, Douglas W. Wilson, Metabolic syndrome: a brain disease Canadian Journal of Physiology and Pharmacology. ,vol. 90, pp. 1171- 1183 ,(2012) , 10.1139/Y2012-122
Sun Gil Kim, Myung Kul Yum, Decreased RR interval complexity and loss of circadian rhythm in patients with congestive heart failure. Japanese Circulation Journal-english Edition. ,vol. 64, pp. 39- 45 ,(2000) , 10.1253/JCJ.64.39
João H. Duarte, Vagal stimulation in patients with HF Nature Reviews Cardiology. ,vol. 11, pp. 621- 621 ,(2014) , 10.1038/NRCARDIO.2014.150
Takuya Kishi, Heart failure as an autonomic nervous system dysfunction. Journal of Cardiology. ,vol. 59, pp. 117- 122 ,(2012) , 10.1016/J.JJCC.2011.12.006